ArticleEmerging microbes & infections2025

SARS-CoV-2 Mpro inhibitor ensitrelvir: asymmetrical cross-resistance with nirmatrelvir and emerging resistance hotspots.

Yuyong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.